A citation-based method for searching scientific literature

Navneeta Bansal, Ashish Gupta, Nilay Mitash, Prashant Singh Shakya, Anil Mandhani, Abbas Ali Mahdi, Satya Narain Sankhwar, Sudhir Kumar Mandal. J Proteome Res 2013
Times Cited: 44







List of co-cited articles
322 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
Nagireddy Putluri, Ali Shojaie, Vihas T Vasu, Shaiju K Vareed, Srilatha Nalluri, Vasanta Putluri, Gagan Singh Thangjam, Katrin Panzitt, Christopher T Tallman, Charles Butler,[...]. Cancer Res 2011
130
52

Diagnosis of bladder cancer and prediction of survival by urinary metabolomics.
Xing Jin, Seok Joong Yun, Pildu Jeong, Isaac Yi Kim, Wun-Jae Kim, Sunghyouk Park. Oncotarget 2014
98
50

NMR-based metabolomic analysis of human bladder cancer.
Ming Cao, Liangcai Zhao, Haige Chen, Wei Xue, Donghai Lin. Anal Sci 2012
59
43

Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry.
Kishore Kumar Pasikanti, Kesavan Esuvaranathan, Yanjun Hong, Paul C Ho, Ratha Mahendran, Lata Raman Nee Mani, Edmund Chiong, Eric Chun Yong Chan. J Proteome Res 2013
73
43

Taurine - a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by 1H NMR spectroscopy.
Shatakshi Srivastava, Raja Roy, Sudhir Singh, Praveen Kumar, Diwakar Dalela, Satya N Sankhwar, Apul Goel, Abhinav A Sonkar. Cancer Biomark 2010
81
40

Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
Juliana Vieira Alberice, Andre F S Amaral, Emily Grace Armitage, José Antonio Lorente, Ferrán Algaba, Emanuel Carrilho, Mirari Márquez, Antonia García, Núria Malats, Coral Barbas. J Chromatogr A 2013
85
38

Bladder cancer biomarker discovery using global metabolomic profiling of urine.
Bryan M Wittmann, Steven M Stirdivant, Matthew W Mitchell, Jacob E Wulff, Jonathan E McDunn, Zhen Li, Aphrihl Dennis-Barrie, Bruce P Neri, Michael V Milburn, Yair Lotan,[...]. PLoS One 2014
75
38

Noninvasive urinary metabonomic diagnosis of human bladder cancer.
Kishore Kumar Pasikanti, Kesavan Esuvaranathan, Paul C Ho, Ratha Mahendran, Revathi Kamaraj, Qing Hui Wu, Edmund Chiong, Eric Chun Yong Chan. J Proteome Res 2010
131
36

HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.
Pratima Tripathi, Bagganahalli S Somashekar, M Ponnusamy, Amy Gursky, Stephen Dailey, Priya Kunju, Cheryl T Lee, Arul M Chinnaiyan, Thekkelnaycke M Rajendiran, Ayyalusamy Ramamoorthy. J Proteome Res 2013
42
35

Bladder cancer determination via two urinary metabolites: a biomarker pattern approach.
Zhenzhen Huang, Lin Lin, Yao Gao, Yongjing Chen, Xiaomei Yan, Jinchun Xing, Wei Hang. Mol Cell Proteomics 2011
78
31

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, Amjad P Khan, Qi Cao, Jindan Yu, Bharathi Laxman, Rohit Mehra, Robert J Lonigro, Yong Li,[...]. Nature 2009
25

Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.
Divya Sahu, Yair Lotan, Bryan Wittmann, Bruce Neri, Donna E Hansel. Cancer Med 2017
40
27

Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
Haleem J Issaq, Ofer Nativ, Timothy Waybright, Brian Luke, Timothy D Veenstra, Elias J Issaq, Alexander Kravstov, Michael Mullerad. J Urol 2008
102
22

Developing urinary metabolomic signatures as early bladder cancer diagnostic markers.
Chong Shen, Zeyu Sun, Deying Chen, Xiaoling Su, Jing Jiang, Gonghui Li, Biaoyang Lin, Jiajun Yan. OMICS 2015
47
22

Metabonomic profiling of bladder cancer.
Eric Chun Yong Chan, Kishore Kumar Pasikanti, Yanjun Hong, Paul C Ho, Ratha Mahendran, Lata Raman Nee Mani, Edmund Chiong, Kesavan Esuvaranathan. J Proteome Res 2015
35
25

Epidemiology and risk factors of urothelial bladder cancer.
Maximilian Burger, James W F Catto, Guido Dalbagni, H Barton Grossman, Harry Herr, Pierre Karakiewicz, Wassim Kassouf, Lambertus A Kiemeney, Carlo La Vecchia, Shahrokh Shariat,[...]. Eur Urol 2013
20

The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism.
Vanessa R Conde, Pedro F Oliveira, Ana R Nunes, Cátia S Rocha, Elsa Ramalhosa, José A Pereira, Marco G Alves, Branca M Silva. Exp Cell Res 2015
55
20

Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
Daniela Rodrigues, Carmen Jerónimo, Rui Henrique, Luís Belo, Maria de Lourdes Bastos, Paula Guedes de Pinho, Márcia Carvalho. Int J Cancer 2016
45
20

NMR-based metabolomics study of canine bladder cancer.
Jian Zhang, Siwei Wei, Lingyan Liu, G A Nagana Gowda, Patty Bonney, Jane Stewart, Deborah W Knapp, Daniel Raftery. Biochim Biophys Acta 2012
49
18

Distinct metabolic differences between various human cancer and primary cells.
Katja Dettmer, Franziska C Vogl, Axel P Ritter, Wentao Zhu, Nadine Nürnberger, Marina Kreutz, Peter J Oefner, Wolfram Gronwald, Eva Gottfried. Electrophoresis 2013
25
32

LC-MS-based serum metabolic profiling for genitourinary cancer classification and cancer type-specific biomarker discovery.
Lin Lin, Zhenzhen Huang, Yao Gao, Yongjing Chen, Wei Hang, Jinchun Xing, Xiaomei Yan. Proteomics 2012
49
18

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
18

The development of plasma pseudotargeted GC-MS metabolic profiling and its application in bladder cancer.
Yang Zhou, Ruixiang Song, Zhensheng Zhang, Xin Lu, Zhongda Zeng, Chunxiu Hu, Xinyu Liu, Yanli Li, Jianguo Hou, Yinghao Sun,[...]. Anal Bioanal Chem 2016
35
22

Metabolic profiles of cancer cells.
Julian L Griffin, John P Shockcor. Nat Rev Cancer 2004
499
15

A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer.
Elodie Jobard, Clément Pontoizeau, Benjamin J Blaise, Thomas Bachelot, Bénédicte Elena-Herrmann, Olivier Trédan. Cancer Lett 2014
90
15

Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
Friedrich-Carl von Rundstedt, Kimal Rajapakshe, Jing Ma, James M Arnold, Jie Gohlke, Vasanta Putluri, Rashmi Krishnapuram, D Badrajee Piyarathna, Yair Lotan, Daniel Gödde,[...]. J Urol 2016
30
23

Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.
Chi-Hung Shao, Chien-Lun Chen, Jia-You Lin, Chao-Jung Chen, Shu-Hsuan Fu, Yi-Ting Chen, Yu-Sun Chang, Jau-Song Yu, Ke-Hung Tsui, Chiun-Gung Juo,[...]. Oncotarget 2017
35
20

Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.
Guangguo Tan, Haibo Wang, Jianlin Yuan, Weijun Qin, Xin Dong, Hong Wu, Ping Meng. Sci Rep 2017
23
30

Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans.
Marianne C Walsh, Lorraine Brennan, J Paul G Malthouse, Helen M Roche, Michael J Gibney. Am J Clin Nutr 2006
189
13

Metabolomics-derived prostate cancer biomarkers: fact or fiction?
Deepak Kumar, Ashish Gupta, Anil Mandhani, Satya Narain Sankhwar. J Proteome Res 2015
42
14

Metabolomics in bladder cancer: a systematic review.
Yidong Cheng, Xiao Yang, Xiaheng Deng, Xiaolei Zhang, Pengchao Li, Jun Tao, Chao Qin, Jifu Wei, Qiang Lu. Int J Clin Exp Med 2015
39
15

Bladder cancer recurrence surveillance by urine metabolomics analysis.
A Loras, M Trassierra, D Sanjuan-Herráez, M C Martínez-Bisbal, J V Castell, G Quintás, J L Ruiz-Cerdá. Sci Rep 2018
33
18


HMDB 3.0--The Human Metabolome Database in 2013.
David S Wishart, Timothy Jewison, An Chi Guo, Michael Wilson, Craig Knox, Yifeng Liu, Yannick Djoumbou, Rupasri Mandal, Farid Aziat, Edison Dong,[...]. Nucleic Acids Res 2013
11

Metabolomics in the study of kidney diseases.
Robert H Weiss, Kyoungmi Kim. Nat Rev Nephrol 2011
163
11

Molecular screening for bladder cancer: progress and potential.
Anirban P Mitra, Richard J Cote. Nat Rev Urol 2010
54
11

Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts.
Olaf Beckonert, Hector C Keun, Timothy M D Ebbels, Jacob Bundy, Elaine Holmes, John C Lindon, Jeremy K Nicholson. Nat Protoc 2007
11

The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions.
Natalie J Serkova, Eduard J Gamito, Richard H Jones, Colin O'Donnell, Jaimi L Brown, Spencer Green, Holly Sullivan, Tammy Hedlund, E David Crawford. Prostate 2008
98
11

Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Joana Carrola, Cláudia M Rocha, António S Barros, Ana M Gil, Brian J Goodfellow, Isabel M Carreira, João Bernardo, Ana Gomes, Vitor Sousa, Lina Carvalho,[...]. J Proteome Res 2011
155
11

Low- and high-grade bladder cancer appraisal via serum-based proteomics approach.
Navneeta Bansal, Ashish Gupta, Satya Narain Sankhwar, Abbas Ali Mahdi. Clin Chim Acta 2014
26
19

Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
Qiang Huang, Yexiong Tan, Peiyuan Yin, Guozhu Ye, Peng Gao, Xin Lu, Hongyang Wang, Guowang Xu. Cancer Res 2013
266
11

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
11

New opportunities from the cancer metabolome.
Omran Abu Aboud, Robert H Weiss. Clin Chem 2013
62
11


Bladder cancer: epidemiology, staging and grading, and diagnosis.
Ziya Kirkali, Theresa Chan, Murugesan Manoharan, Ferran Algaba, Christer Busch, Liang Cheng, Lambertus Kiemeney, Martin Kriegmair, R Montironi, William M Murphy,[...]. Urology 2005
619
11

A molecular taxonomy for urothelial carcinoma.
Gottfrid Sjödahl, Martin Lauss, Kristina Lövgren, Gunilla Chebil, Sigurdur Gudjonsson, Srinivas Veerla, Oliver Patschan, Mattias Aine, Mårten Fernö, Markus Ringnér,[...]. Clin Cancer Res 2012
540
11

Metabolomics analysis for biomarker discovery: advances and challenges.
M S Monteiro, M Carvalho, M L Bastos, P Guedes de Pinho. Curr Med Chem 2013
142
9

Urinary biomarkers of bladder cancer: an update and future perspectives.
Charles J Rosser, Virginia Urquidi, Steve Goodison. Biomark Med 2013
25
16

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.
Vinata B Lokeshwar, Tomonori Habuchi, H Barton Grossman, William M Murphy, Stefan H Hautmann, George P Hemstreet, Aldo V Bono, Robert H Getzenberg, Peter Goebell, Bernd J Schmitz-Dräger,[...]. Urology 2005
290
9

Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.
Carsten Denkert, Jan Budczies, Tobias Kind, Wilko Weichert, Peter Tablack, Jalid Sehouli, Silvia Niesporek, Dominique Könsgen, Manfred Dietel, Oliver Fiehn. Cancer Res 2006
260
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.